Results from a clinical trial show that giving people with high blood pressure an injection every six months can lead to a meaningful, sustained reduction in their blood pressure.

The ELS 200 ml Syringe MU (314626-100) and the Day Safe Syringe 200 (312426-100). Both products will be officially presented ...

YUFLYMA® (adalimumab-aaty) is a high-concentration (100mg/mL) and citrate-free formulation of Humira® (adalimumab) biosimilar ...